Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonization.
Postdischarge risks of vancomycin-resistant Enterococcus (VRE) infection among carriers are unknown. We conducted a retrospective cohort study of 199 patients newly detected as VRE carriers. Fifteen patients (8%) developed 27 VRE infections in the 18 months after detection. Among 10 postdischarge infections, 2 involved bacteremia and 3 resulted in readmission.
Datta
Rupak
R
Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA 92697, USA. rdatta@uci.edu
Huang
Susan S
SS
D000046:Academic Medical Centers; D000368:Aged; D000369:Aged, 80 and over; D016470:Bacteremia / Q000453:epidemiology*; D001900:Boston / Q000453:epidemiology; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology*; D016983:Enterococcus; D005260:Female; D006801:Humans; D008297:Male; D010351:Patient Discharge; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D020713:Vancomycin Resistance